Production —
Training activity: 2

Details

Critically appraise a plan for product validation activities for a new product or process change

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

• Mixing trials and statistical analysis
• Cleaning validation including toxicology and risk to patients
• Process validation
• Documentation
• Scale up
• Sampling and sampling strategies
• Local standard operating procedures (SOPs)
• Equipment validation

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

• What will demonstrate that your appraisal has been sufficiently critical and identified key areas for consideration?
• What insights do you hope to gain into the principles and practices of product validation and how they ensure product quality and safety?
• Consider the differences between validating a new product versus a process change. What specific learning do you anticipate from each scenario?
• How do you expect this activity will improve your understanding of quality assurance in pharmaceutical production?
• Discuss with your training officer the context of the validation plan you will be appraising (e.g., type of product, nature of the process change).
• Anticipate potential areas of weakness in a validation plan. How will you prepare to identify and analyse these critically, perhaps by reviewing regulatory guidelines on validation?
• Reflect on your current understanding of validation. What resources or information might you need to review beforehand to feel more confident in your appraisal?

 

In action

• Pay attention to your actions in appraising the product validation plan.
  • How are you approaching the critical appraisal of the proposed activities for a new product or process change? Why are you doing it this way?
  • What decisions are you making as you evaluate the rationale and scope of the validation activities? For example, how are you determining if the plan is comprehensive enough?
• How effective are your actions in identifying potential strengths and weaknesses in the product validation plan?
  • What challenges are you facing as you critically appraise the different stages and acceptance criteria within the validation plan?
  • What can you learn from the process of appraising this plan as it unfolds? For instance, are you gaining a better understanding of the critical parameters to be validated?
  • How does this activity of appraising a validation plan connect to your existing knowledge of GMP, pharmaceutical quality management systems, and the principles of quality risk management?
• Are there alternative approaches you could be considering for critically appraising the validation plan? For example, are you focusing on the scientific rationale or the practical implementation?
  • What support or guidance might you need in the moment if you encounter unfamiliar validation techniques or regulatory requirements?
  • Are you working within your understanding of process validation principles and their importance for product quality and patient safety?

On action

• What were the key stages and activities included in the product validation plan?
  • What types of validation were proposed (e.g., process validation, analytical method validation)?
  • What criteria and acceptance limits were defined in the plan?
  • Were there clear links between the validation activities and the critical quality attributes of the product or process?
  • Did you notice any potential gaps or areas that required further clarification in the validation plan?
• What did you learn about the importance of product validation in ensuring consistent product quality?
  • How does product validation relate to good manufacturing practice (GMP)?
  • What are the key elements that should be included in a comprehensive product validation plan?
  • Did you gain a better understanding of the regulatory requirements for product validation?
  • How does validation for a new product differ from validation for a process change?
• How will you approach the critical appraisal of product validation plans in your future practice?
  • What key questions will you ask when reviewing validation protocols and reports?
  • How will this learning contribute to your understanding of pharmaceutical quality management systems?

Beyond action

• Have you re-evaluated your initial appraisal of the product validation plan considering experiences from subsequent training activities, particularly those involving manufacturing or quality assurance?
  • How does your understanding of product validation for new products or process changes now compare with your initial appraisal?
  • Have discussions with your training officer or colleagues about validation principles provided new insights or perspectives on your original appraisal?
• How has appraising a validation plan influenced your understanding of the importance of process validation in ensuring the provision of high-quality, safe pharmaceutical products?
  • Has this experience informed your approach to reviewing validation documentation or considering the impact of process changes in other areas of your work?
  • Have you applied the principles of critical appraisal learned in this training activity to the evaluation of other plans or documents in your training?
  • How has this training activity contributed to your understanding of the learning outcomes related to applying the principles of GMP to the development of new products?
• How will your understanding of product validation inform your future involvement in manufacturing, quality control, or quality assurance activities?
  • What aspects of planning and critically appraising validation activities do you recognise as key skills for your future role as a clinical pharmaceutical scientist?
  • What further learning or experience do you need to develop a more comprehensive understanding of product and process validation?

Relevant learning outcomes

#	Outcome
# 1	Outcome Describe the working practices of pharmaceutical production.
# 2	Outcome Apply the principles of good manufacturing practice (GMP) to the development of new products.
# 3	Outcome Perform a range of manufacturing activities, using specialist equipment, in accordance with requirements for GMP and pharmaceutical quality management systems.
# 4	Outcome Apply the principles of supplier approval and quality assessment to evaluate a range of starting materials and packaging components.
# 5	Outcome Perform activities to support safe storage and distribution of medicinal products applying the principles of Good Distribution Practice (GDP).
# 6	Outcome Apply the principles of quality risk management to the manufacturing process.